PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 5, 2026Egyptian Journal of Chest Diseases and Tuberculosis0 citationsOpen Access

A study of the prevalence of hepatopulmonary syndrome in chronic liver cirrhosis patients, and the various predictive cut-off values for arterial oxygenation and their clinical consequences

View Full Paper
AEAmira A. ElKholyGAGhada A. AttiaYMYoussef Mohamed Mansour

Key Points

  • This research aims to assess the prevalence of hepatopulmonary syndrome (HPS) among chronic liver cirrhosis patients and evaluate the prognostic significance of arterial oxygenation thresholds.
  • Conducted a descriptive cross-sectional study involving 100 patients with chronic liver cirrhosis and probable HPS.
  • Patients were divided into two groups based on echocardiography results: HPS and non-HPS.
  • Evaluated clinical symptoms and laboratory markers related to oxygenation and liver function.
  • HPS was identified in 7% of cirrhotic patients with significant hypoxemia.
  • Group I (HPS) exhibited lower arterial oxygen partial pressure and higher alveolar-arterial difference compared to Group II (non-HPS).
  • Statistical significance was found for symptoms and laboratory values, such as lower blood albumin and higher serum bilirubin in Group I.

Abstract

Background Hepatopulmonary syndrome (HPS) distinguished by hypoxemia resulting from dilatation of the pulmonary vasculature. This study aimed to examine the prevalence and prognostic value of different arterial oxygenation thresholds among individuals diagnosed with chronic liver cirrhosis, with a particular emphasis on the HPS. Method A total of 100 individuals with probable HPS and liver cirrhosis participated in this descriptive cross-sectional investigation. Patients were categorized into two groups. Group I (HPS): positive agitated echocardiography. Group II (non-HPS): negative agitated echocardiography. Results Platypnea, cyanosis, and orthodeoxia were seen in group (I) with a significant statistical value ( P =0.0001). On the other hand, orthopnea was discovered in 20 (21.5%) patients in group (II) but not in any patients in group (I), with a significant statistical value ( P =0.005). Both the severity ofwaser disease as measured by the Child–Pugh scale ( P =0.034) and the etiology of cirrhosis ( P =0.038) were significantly different across the categories. In comparison to group II, group I had lower blood albumin and higher serum bilirubin levels on average. The two groups were significantly different from one another ( P =0.025 and P =0.04, respectively). The average arterial oxygen partial pressure (PaO 2 ) was lower in group I than in group II. On the other hand, group I had a significantly greater mean alveolar-arterial difference in oxygen partial pressure (AaDO 2 ) than group II ( P =0.008). Conclusion HPS prevalence among cirrhotic patients was low (7%). Arterial oxygenation thresholds, along with other clinical and laboratory markers, can serve as valuable prognostic indicators in patients with chronic liver cirrhosis, particularly in HPS.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

ElKholy et al. (2026) studied this question.

synapsesocial.com/papers/69843451f1d9ada3c1fb24ddhttps://doi.org/10.4103/ecdt.ecdt_97_23
Ask AI
Helpful
Bookmark
Share
View Full Paper